FDA Creates ‘Green List’ of GLP-1 Drug Ingredients Approved for Entry in the U.S.
2025-09-05
The purpose of the list is to keep unverified and unapproved GLP-1 drug ingredients from entering the countryContinue Reading
Wegovy Linked To Lower Heart Risks Than Similar Drugs, Study Shows
2025-09-03
WEDNESDAY, Sept. 3, 2025 (HealthDay News) — The weight-loss drug Wegovy may lower the risk of heart attack, stroke or death more than similar medications, according to new research from its maker, Novo Nordisk. In a study of more than 21,000 patients with obesity and heart disease but no diabetes,Continue Reading
New GLP-1 Pill Helps People Lose 23 Pounds in Study
2025-08-27
WEDNESDAY, Aug. 27, 2025 (HealthDay News) — Eli Lilly says its new once-daily pill, orforglipron, helped people lose significant weight and lower blood sugar in a late-stage clinical trial. The company plans to seek global regulatory approval later this year. The study included people with overweight, obesity and type 2Continue Reading
FDA Clears OTC Glucose Monitoring System for Weight Management
2025-08-22
System integrates glucose biosensor with an AI-driven platform to show how food, activity, stress, sleep affect the body in real timeContinue Reading
Diabetes Risk Clusters In Households
2025-08-19
TUESDAY, Aug. 19, 2025 (HealthDay News) — Diabetes risk appears to cluster in households, a new study says. Three-quarters of people at risk for developing type 2 diabetes are living under the same roof as another person who either already has diabetes or carries risk factors for the condition, researchersContinue Reading
New Blood Pressure Guidelines Highlight Lifestyle Changes, Tailored Treatment
2025-08-15
FRIDAY, Aug. 15, 2025 (HealthDay News) — Nearly half of U.S. adults should receive earlier treatment for high blood pressure, including lifestyle changes and medications, according to a set of new guidelines issued by America’s top heart health groups. The guidelines call for early and more individualized treatment for theContinue Reading
-690x550.jpg)
A Doctor’s Guide to Intermittent Fasting: Is It Right for You?
2025-08-12
TUESDAY, Aug. 12, 2025 (HealthDay News) — As a bariatric surgeon, I talk with patients every day about weight loss and improving their overall health. One topic that comes up more and more is intermittent fasting. You’ve probably heard about it from a friend, seen it on social media orContinue Reading
New Weight Loss Pill From Eli Lilly Shows Promise in Early Study
2025-08-08
FRIDAY, Aug. 8, 2025 (HealthDay News) — A new weight loss pill made by Eli Lilly helped people lose a significant amount of weight in a recent study. Taken at the highest dose, orforglipron helped patients lose an average 27.3 pounds, or 12.4% of their body weight, over 72 weeks.Continue Reading
1 in 10 Americans Has Used GLP-1 Drugs For Weight Loss, Survey Says
2025-08-08
FRIDAY, Aug. 8, 2025 (HealthDay News) — More than 1 in 10 Americans have used a GLP-1 drug for weight loss, a new survey by the RAND research group reveals. About 12% say they’ve tried GLP-1 drugs, like Ozempic, Wegovy or Zepbound, with rates of use highest among people agesContinue Reading
Experts Recommend Healthy Lifestyle Changes Alongside GLP-1 Drug Use
2025-07-16
WEDNESDAY, July 16, 2025 (HealthDay News) — GLP-1 weight-loss drugs like Ozempic and Zepbound are so effective it might seem that a person can lose weight without doing anything at all. But that’s a false notion, experts say. Losing weight properly and keeping it off will require lifestyle changes thatContinue Reading